Timothy Chiang

Stock Analyst at Capital One

(0.18)
# 2,936
Out of 4,490 analysts
6
Total ratings
20%
Success rate
-12.25%
Average return

5 Stocks

ANI Pharmaceuticals
Mar 15, 2024
Initiates: Overweight
Price Target: n/a
Current: $62.98
Upside: -
Akoya Biosciences
Nov 3, 2022
Initiates: Overweight
Price Target: $19
Current: $2.60
Upside: +630.77%
Protagonist Therapeutics
Feb 11, 2022
Initiates: Buy
Price Target: $55
Current: $35.92
Upside: +53.12%
Amphastar Pharmaceuticals
Oct 5, 2020
Upgrades: Outperform
Price Target: n/a
Current: $39.42
Upside: -
IDEAYA Biosciences
Sep 1, 2020
Initiates: Outperform
Price Target: n/a
Current: $40.71
Upside: -